Schedule 13G ownership disclosure

BRIACELL THERAPEUTICS CORP

Common Shares, no par value · CUSIP: 107930307

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Iroquois Capital Management, LLC

    Shares: 57,200.00 · Class: 2.95%

  • Richard Abbe

    Shares: 98,944.00 · Class: 4.99%

  • Kimberly Page

    Shares: 57,200.00 · Class: 2.95%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-25-003462
Form type
SCHEDULE 13G/A
Filer
Bionano Genomics, Inc.
CIK
CIK 1411690
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub